You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
BIM<br />
Turkey/Food & Drug Retailers Analyser<br />
BIM (Hold)<br />
Hold<br />
Recommendation unchanged<br />
Share price: TRY<br />
closing price as of 07/05/2012<br />
Target price: TRY<br />
Target Price unchanged<br />
Reuters/Bloomberg<br />
70.00<br />
56.00<br />
BIMAS.IS/BIMAS TI<br />
Market capitalisation (TRYm) 10,626<br />
Current N° of shares (m) 152<br />
Free float 65%<br />
Daily avg. no. trad. sh. 12 mth 219,503<br />
Daily avg. trad. vol. 12 mth (m) 12<br />
Price high 12 mth (TRY) 73.25<br />
Price low 12 mth (TRY) 47.20<br />
Abs. perf. 1 mth 4.87%<br />
Abs. perf. 3 mth 14.75%<br />
Abs. perf. 12 mth 37.25%<br />
Key financials (TRY) 12/10 12/11e 12/12e<br />
Sales (m) 6,574 8,115 9,697<br />
EBITDA (m) 361 433 508<br />
EBITDA margin 5.5% 5.3% 5.2%<br />
EBIT (m) 296 354 418<br />
EBIT margin 4.5% 4.4% 4.3%<br />
Net Profit (adj.)(m) 246 297 358<br />
ROCE 84.2% 88.3% 84.8%<br />
Net debt/(cash) (m) (250) (330) (418)<br />
Net Debt/Equity -0.5 -0.5 -0.5<br />
Debt/EBITDA -0.7 -0.8 -0.8<br />
Int. cover(EBITDA/Fin. int) (34.9) (20.8) (17.7)<br />
EV/Sales 1.2 0.9 1.1<br />
EV/EBITDA 21.4 17.7 20.1<br />
EV/EBITDA (adj.) 21.4 17.7 20.1<br />
EV/EBIT 26.1 21.6 24.4<br />
P/E (adj.) 32.4 26.8 29.7<br />
P/BV 15.9 13.0 13.6<br />
OpFCF yield 4.4% 5.6% 4.8%<br />
Dividend yield 1.7% 1.8% 2.2%<br />
EPS (adj.) 1.62 1.96 2.36<br />
BVPS 3.30 4.05 5.14<br />
DPS 1.20 1.27 1.53<br />
75 vvdsvdvsdy<br />
70<br />
65<br />
60<br />
55<br />
50<br />
45<br />
40<br />
Apr 11 May 11 Jun 11 Jul 11 Aug 11 Sep 11 Oct 11 Nov 11 Dec 11 Jan 12 Feb 12 Mar 12 Apr 12 May 12<br />
Source: Factset<br />
BIM ISE NATIONAL 100 (Rebased)<br />
Shareholders: Mustafa Latif Topbas 17%; Ahmet Afif<br />
Topbas 9%; Abdulrahman El Khereiji 7%;<br />
Analyst(s):<br />
Natalia Svyrou-Svyriadi, Marfin Analysis<br />
nsviriadi@ibg.gr<br />
+30 210 81 73 384<br />
Strong 1Q12 results<br />
The facts: BIM announced strong results for the first quarter of 2012, beating<br />
consensus estimates (Bloomberg, 14 analysts). Specifically, revenues grew by<br />
29% y-o-y to TRY 2,428m (4% above consensus), EBITDA came in at TRY<br />
130.7m (+17% y-o-y, 10% above consensus), while net profits settled at TRY<br />
90.7m (+13.7% y-o-y, 6.5% above consensus). On the operational front, BIM<br />
opened 91 new stores in Turkey and 9 new stores in Morocco which contributed to<br />
the top line growth. On a like-for-like basis, BIM‟s turnover rose by 19% y-o-y to<br />
TRY 1,964m.<br />
BIM’s 1Q12 results<br />
TRY m 1Q11 1Q12 % YoY<br />
Sales 1,877.9 2,428.0 29.3%<br />
Reported EBITDA 111.6 130.7 17.1%<br />
Net profit 79.8 90.7 13.7%<br />
Source: The Company, IBG<br />
Our analysis: The positive surprise on the bottom line should be attributed to the<br />
stronger than expected sales growth and a higher EBITDA margin (5.4% vs.<br />
consensus estimate for 5.1%). On the flip side, the EBITDA margin dropped by<br />
50bps y-o-y as the management is currently implementing its expansionary plans<br />
in Morocco and Egypt.<br />
Conclusion & Action: On the whole, the company maintained its rising<br />
momentum and pleasantly surprised the market. The company will host a<br />
conference call today at 16:30 Istanbul time (14:30 London time). We are in the<br />
process of adjusting our forecasts and target price for the stock.<br />
Page 15 of 80 European Securities Network<br />
Please refer to important disclaimer on the last page